What Is the Prognosis of an Acute Myocardial Infarction in the Presence of Moderate Aortic Stenosis?

Aortic stenosis (AS) is a common condition that shares risk factors with coronary artery disease. Many patients can suffer from both diseases simultaneously, something that increases the risk of acute myocardial infarction in the presence of aortic stenosis.

¿Cuál es el pronóstico de un infarto agudo de miocardio en presencia de estenosis aórtica moderada?

AS can cause ischemia even in the absence of coronary artery disease, due to ventricular hypertrophy, increased ventricular loads, and microcirculation disorders.

The presence of moderate AS in acute coronary syndrome can influence its clinical course. While there are several published works on this topic, the best strategy to follow is still unclear, as current guidelines do not provide specific recommendations in this regard.

A retrospective analysis was conducted on 1373 patients who experienced acute coronary syndrome, with or without ST-segment elevation, between 2005 and 2016. Of these, 183 patients (13.3%) had moderate aortic stenosis, while the remaining 1190 either did not have it or had mild stenosis.

Patients with moderate AS were older and had a higher prevalence of comorbidities such as diabetes, hypertension, dyslipidemia, myocardial infarction, myocardial revascularization surgery (MRS), stroke, impaired renal function, and a lower left ventricular ejection fraction (48.3 ± 13.5 vs. 51.4 ± 12.3, p = 0.006).

Read also: Is Edge-to-Edge Treatment with PASCAL Effective at 3 Years?

There were no differences in terms of access used, but the number of diseased vessels and the number of stents used were higher in patients with moderate aortic stenosis.

During hospitalization, there were no differences in terms of mortality or cardiogenic shock between the groups, but the heart failure rate was higher in patients with moderate aortic stenosis compared to those without stenosis or with mild stenosis.

At the one-year follow-up, mortality was higher in the group with moderate aortic stenosis (23.9% vs. 8.1%, p < 0.001), and so were hospitalizations for heart failure (8.3% vs. 3.7%, p = 0.028).

During hospitalizations for heart failure, mortality was higher for patients with moderate aortic stenosis both in-hospital and at one year, but there were no differences in those with mild aortic stenosis or without stenosis.

Read also: Relationship between Distal Vessel Quality and Outcomes in the Treatment of Chronic Total Occlusions.

In a multivariate analysis, the presence of moderate aortic stenosis was associated with a 2.4-fold increase in mortality in patients with acute coronary syndrome, whether with or without ST-segment elevation and moderate aortic stenosis.

Conclusion

The presence of moderate aortic stenosis in patients with acute myocardial infarction was associated with an unfavorable clinical course during hospitalization and at a one-year follow-up. These findings highlight the importance of close monitoring of these patients and determining the best treatment strategy based on existing conditions.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study.

Reference: Abraham, et al.Catheter Cardiovasc Interv. 2023;102:159–165.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...